<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Merial launches new cancer treatment for cats </title><link>/b/veterinary-nursing-news/posts/148212</link><description> Merial has announced the launch of Oncept IL-2, the first veterinary immunotherapeutic product in Europe for the management of cancer in pets. 
 Described by the company as a true breakthrough in the field of veterinary oncology, Oncept IL-2 is an adjunct</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>